ECM
COLL icon

EagleClaw Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

EagleClaw Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,850
Closed -$164K – 123
2019
Q1 		$164K Buy
+10,850
New +$174K 0.07% 117
2018
Q3 		– Sell
-8,600
Closed -$206K – 122
2018
Q2 		$206K Hold
8,600
– – 0.1% 112
2018
Q1 		$220K Buy
+8,600
New +$205K 0.11% 107

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

EagleClaw Capital Management's COLL Position: Q2 2019 in Review

EagleClaw Capital Management sold out of Collegium Pharmaceutical (COLL) in Q2 2019, closing a stake of 10,850 shares — an estimated $164K sold.

EagleClaw Capital Management first reported a position in COLL in Q1 2018 and held it in 3 quarters. The position peaked at $220K in Q1 2018. 128 funds tracked by Wall St. Rank hold COLL as of Q2 2019.

  • EagleClaw Capital Management reported no remaining Collegium Pharmaceutical position as of Q2 2019 after selling out during the quarter.
  • EagleClaw Capital Management sold 10,850 Collegium Pharmaceutical shares in Q2 2019, an estimated $164K.
  • EagleClaw Capital Management first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 3 quarters.
  • EagleClaw Capital Management's Collegium Pharmaceutical position peaked at $220K in Q1 2018.
  • 128 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2019.

Based on EagleClaw Capital Management's 13F filing for Q2 2019, filed 18 Jul 2019.